Optimizing drug delivery to brain tumors.

Suppr

超能文献

作者信息

Greig N H

出版信息

Cancer Treat Rev. 1987 Mar;14(1):1-28. doi: 10.1016/0305-7372(87)90048-x.

DOI:10.1016/0305-7372(87)90048-x

PMID:3297321

Abstract

摘要

相似文献

Optimizing drug delivery to brain tumors.

Cancer Treat Rev. 1987 Mar;14(1):1-28. doi: 10.1016/0305-7372(87)90048-x.

Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.

Cancer Treat Rep. 1977 Jul;61(4):519-26.

Drug delivery to brain tumors.

Bull Math Biol. 1996 Nov;58(6):1047-74. doi: 10.1007/BF02458383.

Proceedings: Factors influencing the outcome of chemotherapy of brain tumors.

Proc Natl Cancer Conf. 1972;7:805-9.

Novel modes of chemotherapy administration.

Prog Exp Tumor Res. 1984;28:32-50. doi: 10.1159/000408236.

Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.

Curr Clin Pharmacol. 2018;13(2):110-119. doi: 10.2174/1574884713666180412150153.

CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption.

Clin Neurosurg. 1981;28:520-31. doi: 10.1093/neurosurgery/28.cn_suppl_1.520.

Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.

Cancer Treat Rep. 1977 Jul;61(4):527-31.

Pharmacodynamics and the blood-brain barrier.

Natl Cancer Inst Monogr. 1977 Dec;46:19-27.

Blood-brain barrier and drug delivery in central nervous system tumors.

Ann Neurol. 1987 Jun;21(6):614-5. doi: 10.1002/ana.410210622.

引用本文的文献

Intraosseous administration into the skull: Potential blood-brain barrier bypassing route for brain drug delivery.

Bioeng Transl Med. 2022 Oct 21;8(2):e10424. doi: 10.1002/btm2.10424. eCollection 2023 Mar.

RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours.

CNS Drugs. 1997 Apr;7(4):257-63. doi: 10.2165/00023210-199707040-00001.

Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression.

CNS Neurol Disord Drug Targets. 2014;13(8):1413-26. doi: 10.2174/1871527313666141023121550.

Current approaches to enhance CNS delivery of drugs across the brain barriers.

Int J Nanomedicine. 2014 May 10;9:2241-57. doi: 10.2147/IJN.S61288. eCollection 2014.

Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.

Neoplasia. 2013 Apr;15(4):384-98. doi: 10.1593/neo.13148.

Strategies for enhanced drug delivery to the central nervous system.

Indian J Pharm Sci. 2008 Mar-Apr;70(2):145-53. doi: 10.4103/0250-474X.41446.

Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

J Transl Med. 2009 Sep 1;7:77. doi: 10.1186/1479-5876-7-77.

The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain.

Pharm Res. 1995 Dec;12(12):1924-31. doi: 10.1023/a:1016239822287.

Intravenously injected radiolabelled fatty acids image brain tumour phospholipids in vivo: differential uptakes of palmitate, arachidonate and docosahexaenoate.

Clin Exp Metastasis. 1993 Mar;11(2):141-9. doi: 10.1007/BF00114972.

Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.

Clin Exp Metastasis. 1993 Mar;11(2):131-40. doi: 10.1007/BF00114971.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验